Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Editorial: The role of mainten...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Editorial: The role of maintenance therapy (immunotherapy, targeted therapy, etc) in cancer control and biologic behavior of recurrent/metastatic cervical cancer

Editorial: The role of maintenance therapy (immunotherapy, targeted therapy, etc) in cancer control and biologic behavior of recurrent/metastatic cervical cancer

Bibliographic Details
Main Authors: Xiaolin Li, Xianzheng Zhang, Aihua Li, Peng Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
cervical cancer
immune microenvironment
immunotherapy
PD-1
TCGA
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1281775/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1281775/full

Similar Items

  • Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer
    by: Xuewei Xing, et al.
    Published: (2023-01-01)
  • Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis
    by: Qian Chen, et al.
    Published: (2021-03-01)
  • Integrative Bioinformatics Approaches to Screen Potential Prognostic Immune-Related Genes and Drugs in the Cervical Cancer Microenvironment
    by: Zitong Zhao, et al.
    Published: (2020-07-01)
  • PD-1/PD-L1 inhibitors for advanced or metastatic cervical cancer: From bench to bed
    by: Weijia Huang, et al.
    Published: (2022-10-01)
  • Pattern of disease and response to pembrolizumab in recurrent cervical cancer
    by: Kathryn M. Miller, et al.
    Published: (2021-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs